{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T05:56:14Z","timestamp":1720245374344},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,6]]},"DOI":"10.7759\/cureus.12534","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:50:06Z","timestamp":1609980606000},"source":"Crossref","is-referenced-by-count":3,"title":["A Rare Case of Acute Pericarditis Due to SARS-CoV-2 Managed With Aspirin and Colchicine"],"prefix":"10.7759","author":[{"given":"Komandur","family":"Thrupthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adithya","family":"Ganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trishna","family":"Acherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maham A","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trupti","family":"Vakde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu X","year":"2020","unstructured":"Xu X, Chen P, Wang J, et al.. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life sci. 2020, 63:457-460. 10.1007\/s11427-020-1637-5","journal-title":"Sci China Life sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-1062. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jocs.14538","article-title":"Cardiac involvement in COVID-19 patients: risk factors, predictors, and complications: a review","volume":"35","author":"Aghagoli G","year":"2020","unstructured":"Aghagoli G, Marin BG, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: risk factors, predictors, and complications: a review. J Card Surg. 2020, 35:1302-1305. 10.1111\/jocs.14538","journal-title":"J Card Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng YY","year":"2020","unstructured":"Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020, 17:259-260. 10.1038\/s41569-020-0360-5","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","volume":"172","author":"Lauer SA","year":"2020","unstructured":"Lauer SA, Grantz KH, Bi Q, et al.. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020, 172:577-582. 10.7326\/M20-0504","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with covid-19","volume":"382","author":"Vaduganathan M","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with covid-19. N Engl J Med. 2020, 382:1653-1659. 10.1056\/NEJMsr2005760","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki K","year":"2020","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020, 215:108427. 10.1016\/j.clim.2020.108427","journal-title":"Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or moderate covid-19","volume":"383","author":"Gandhi RT","year":"2020","unstructured":"Gandhi RT, Lynch JB, del Rio C. Mild or moderate covid-19. N Engl J Med. 2020, 383:1757-1766. 10.1056\/NEJMcp2009249","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi S","year":"2020","unstructured":"Shi S, Qin M, Shen B, et al.. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020, 5:802-810. 10.1001\/jamacardio.2020.0950","journal-title":"JAMA Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref11","article-title":"Diagnosis of acute pericarditis","volume":"15","author":"Xanthopoulos A","year":"2017","unstructured":"Xanthopoulos A, Skoularigis J. Diagnosis of acute pericarditis. E-J Cardiol Pract. 2017, 15:","journal-title":"E-J Cardiol Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.986372","article-title":"Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis","volume":"123","author":"Imazio M","year":"2011","unstructured":"Imazio M, Brucato A, Maestroni S, Cumetti D, Dominelli A, Natale G, Trinchero R. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011, 123:1092-1097. 10.1161\/CIRCULATIONAHA.110.986372","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.02.002","article-title":"Guidelines on the diagnosis and management of pericardial diseases executive summary: the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology","volume":"25","author":"Maisch B","year":"2004","unstructured":"Maisch B, Seferovi\u0107 PM, Risti\u0107 AD, et al.. Guidelines on the diagnosis and management of pericardial diseases executive summary: the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J. 2004, 25:587-610. 10.1016\/j.ehj.2004.02.002","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/12.suppl_D.81","article-title":"Prognostic determinants in conventionally treated myocarditis and perimyocarditis\u2014focus on antimyolemmal antibodies","volume":"12","author":"Maisch B","year":"1991","unstructured":"Maisch B, Outzen H, Roth D, et al.. Prognostic determinants in conventionally treated myocarditis and perimyocarditis\u2014focus on antimyolemmal antibodies. Eur Heart J. 1991, 12:81-87. 10.1093\/eurheartj\/12.suppl_D.81","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2020.1023","article-title":"COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?","volume":"14","author":"Russell B","year":"2020","unstructured":"Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?. Ecancermedicalscience. 2020, 14:1023. 10.3332\/ecancer.2020.1023","journal-title":"Ecancermedicalscience"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.97.21.2183","article-title":"Colchicine treatment for recurrent pericarditis. A decade of experience","volume":"97","author":"Adler Y","year":"1998","unstructured":"Adler Y, Finkelstein Y, Guindo J, et al.. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation. 1998, 97:2183-2185. 10.1161\/01.cir.97.21.2183","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa033","article-title":"Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?","volume":"6","author":"Deftereos S","year":"2020","unstructured":"Deftereos S, Giannopoulos G, Vrachatis DA, et al.. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?. Eur Heart J - Cardiovasc Pharmacother. 2020, 6:255. 10.1093\/ehjcvp\/pvaa033","journal-title":"Eur Heart J - Cardiovasc Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39473-a-rare-case-of-acute-pericarditis-due-to-sars-cov-2-managed-with-aspirin-and-colchicine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:15Z","timestamp":1707507135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39473-a-rare-case-of-acute-pericarditis-due-to-sars-cov-2-managed-with-aspirin-and-colchicine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.12534","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,6]]}}}